GO:0019777 Atg12 transferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019777 (Atg12 transferase activity) catalyzes the covalent transfer of ATG12 from an X-ATG12 conjugate to a target protein Y, forming a Y-ATG12 linkage.
• This activity is essential for canonical autophagy, where ATG12 is conjugated to ATG5 and then associates with ATG16L1 to form the ATG12-ATG5-ATG16L1 complex.
• The ATG12-ATG5-ATG16L1 complex acts as an E3-like enzyme for LC3 lipidation, a critical step in autophagosome formation.
• Dysregulation of Atg12 transferase activity is linked to cancer, neurodegenerative diseases, and metabolic disorders [1,3,4].
• Small-molecule inhibitors targeting the Atg12-Atg3 interaction are being developed as potential therapeutics.
• CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect the precise roles of ATG12 conjugation in health and disease [1,7].
Description
Atg12 transferase activity (GO:0019777) is a molecular function that catalyzes the transfer of ATG12 from one protein to another via a covalent linkage, as defined by the Gene Ontology Consortium. This activity is a cornerstone of the ubiquitin-like conjugation systems that drive autophagy, a conserved cellular degradation pathway. The reaction can be summarized as X-ATG12 + Y = Y-ATG12 + X, where both X-ATG12 and Y-ATG12 are covalent conjugates. In canonical autophagy, ATG12 is transferred to ATG5, forming an ATG12-ATG5 conjugate that further interacts with ATG16L1 to create a complex with E3-like activity for LC3 lipidation. This process is vital for autophagosome formation and cellular homeostasis. Researchers study Atg12 transferase activity to understand autophagy regulation, its role in diseases such as cancer and neurodegeneration, and to develop targeted therapies [1,3,4]. The activity is also implicated in non-canonical autophagy pathways, for example, in response to hypoxia and in antibacterial defense.
Atg12 transferase activity At A Glance
| GO ID | GO:0019777 |
|---|---|
| GO term | Atg12 transferase activity |
| Ontology | molecular_function |
| Synonym | APG12 conjugating enzyme activity, APG12 ligase activity, Atg12 conjugating enzyme activity, Atg12 ligase activity |
| Major function | Catalyzes the covalent transfer of ATG12 to target proteins, forming Y-ATG12 conjugates |
| Reaction | X-ATG12 + Y = Y-ATG12 + X |
| Cellular context | Cytosol; involved in autophagosome formation |
| Related process | Autophagy (GO:0006914) |
What Is GO:0019777?
According to QuickGO, Atg12 transferase activity (GO:0019777) is defined as the catalysis of the transfer of ATG12 from one protein to another via the reaction X-ATG12 + Y = Y-ATG12 + X, where both X-ATG12 and Y-ATG12 are covalent linkages. In simpler terms, it is an enzymatic activity that moves the small protein ATG12 from a donor protein to an acceptor protein, forming a stable covalent bond. This activity is synonymous with APG12 conjugating enzyme activity, APG12 ligase activity, Atg12 conjugating enzyme activity, and Atg12 ligase activity. It is a molecular function that is essential for the conjugation of ATG12 to target proteins like ATG5, a key step in autophagy.
Why Is Atg12 transferase activity Important in Cell Biology?
Atg12 transferase activity is critical for autophagy, a fundamental cellular process that maintains homeostasis by degrading damaged organelles and proteins. This activity enables the formation of the ATG12-ATG5-ATG16L1 complex, which is required for LC3 lipidation and autophagosome elongation. Dysregulation of this activity has been implicated in various human diseases, including cancer, where autophagy can either promote survival or cell death depending on context, and in metabolic disorders such as diabetic kidney disease. Understanding Atg12 transferase activity provides insights into autophagy mechanisms and offers potential therapeutic targets for modulating autophagy in disease.
• Essential for canonical autophagy and autophagosome formation.
• Involved in non-canonical autophagy pathways, such as hypoxia-induced autophagy.
• Plays a role in antibacterial defense through enhanced autophagy.
• Implicated in cancer progression and chemoresistance.
• Linked to neurodegenerative diseases via impaired autophagy.
• Associated with metabolic disorders like diabetic kidney disease.
• Target for small-molecule inhibitors that disrupt Atg12-Atg3 interaction.
• Required for the degradation of polyneddylated proteins by autophagy.
• Coordinates with lysosomal damage response pathways involving PRKAA2, MTOR, and TFEB.
• Potential biomarker for autophagy-related diseases.
What Happens During Atg12 transferase activity?
Activation of ATG12 by ATG7
In simple terms: First, ATG12 is activated by the enzyme ATG7, similar to how ubiquitin is activated.
In the initial step of the ATG12 conjugation cascade, the E1-like enzyme ATG7 activates ATG12 in an ATP-dependent manner, forming a thioester bond between the C-terminal glycine of ATG12 and a cysteine residue in ATG7. This activation is a prerequisite for the subsequent transfer of ATG12 to ATG10.
Transfer of ATG12 to ATG10
In simple terms: Next, ATG12 is passed to a second enzyme, ATG10.
The activated ATG12 is then transferred to the E2-like enzyme ATG10 via a trans-thioesterification reaction, resulting in an ATG12-ATG10 thioester intermediate. This step is analogous to the transfer of ubiquitin from E1 to E2 enzymes.
Conjugation of ATG12 to ATG5
In simple terms: Finally, ATG12 is attached to its target protein, ATG5.
The ATG12-ATG10 thioester intermediate interacts with the target protein ATG5, facilitating the formation of an isopeptide bond between the C-terminal glycine of ATG12 and a lysine residue in ATG5. This reaction is catalyzed by the Atg12 transferase activity (GO:0019777) and results in the stable ATG12-ATG5 conjugate.
Formation of the ATG12-ATG5-ATG16L1 complex
In simple terms: The ATG12-ATG5 conjugate then binds to ATG16L1 to form a larger complex.
The ATG12-ATG5 conjugate non-covalently associates with ATG16L1 to form the ATG12-ATG5-ATG16L1 complex. This complex localizes to the phagophore and functions as an E3-like enzyme for the lipidation of LC3 family proteins, a crucial step in autophagosome membrane elongation.
Role in LC3 lipidation and autophagosome formation
In simple terms: This complex helps attach LC3 to the autophagosome membrane, allowing the autophagosome to form.
The ATG12-ATG5-ATG16L1 complex facilitates the conjugation of LC3 to phosphatidylethanolamine (PE) on the autophagosomal membrane. This lipidation is essential for autophagosome formation and cargo recruitment. The WD40 domain of ATG16L1 is required for its non-canonical role in LC3 lipidation at single membranes, highlighting the versatility of the ATG12 conjugation system.
Key Genes Involved in GO:0019777 Atg12 transferase activity
The following genes and proteins are key players in Atg12 transferase activity and its associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATG12 | Ubiquitin-like protein transferred to ATG5 | Core component of the conjugation system; knockout leads to autophagy defects |
| ATG5 | Target of ATG12 conjugation | Essential for autophagosome formation; mutations linked to disease |
| ATG7 | E1-like activating enzyme for ATG12 | Required for ATG12 activation; knockout inhibits autophagy |
| ATG10 | E2-like conjugating enzyme for ATG12 | Facilitates transfer of ATG12 to ATG5 |
| ATG16L1 | Binds ATG12-ATG5 conjugate | Forms E3-like complex for LC3 lipidation; WD40 domain important for non-canonical functions |
| MAP1LC3B | LC3 family protein lipidated by ATG12-ATG5-ATG16L1 | Marker of autophagosomes; used to monitor autophagy flux |
| SIRT1 | Regulates autophagy via AMPK signaling | Modulates autophagy in cancer cells; potential target |
| AMPK | Energy sensor that activates autophagy | Phosphorylates and regulates autophagy components |
| HIF1A | Hypoxia-inducible factor | Regulates non-canonical autophagy under hypoxia |
| NFAT5 | Transcription factor involved in osmotic stress | Coordinates antibacterial defense with autophagy |
| PRKAA2 | Catalytic subunit of AMPK | Regulates lysosomal damage response and autophagy |
| MTOR | Negative regulator of autophagy | Inhibits autophagy under nutrient-rich conditions |
| TFEB | Transcription factor for autophagy genes | Promotes autophagy and lysosomal biogenesis |
| HYPK | Huntingtin-interacting protein K | Coordinates degradation of polyneddylated proteins by autophagy |
| ESRRA | Estrogen-related receptor alpha | Regulates mitophagy via ATG5 in diabetic kidney disease |
| ATG3 | E2-like enzyme for LC3 lipidation | Target for small-molecule inhibitors of Atg12-Atg3 interaction |
How Is Atg12 transferase activity Regulated?
Atg12 transferase activity is tightly regulated at multiple levels. The expression of core components such as ATG12, ATG5, ATG7, and ATG10 is controlled by transcription factors like TFEB, which promotes autophagy gene expression in response to stress. The activity is also regulated by post-translational modifications; for example, phosphorylation of ATG16L1 by AMPK may modulate complex formation. Nutrient signaling through mTOR inhibits autophagy by phosphorylating ATG proteins, including those involved in ATG12 conjugation. Additionally, hypoxia can induce non-canonical autophagy independent of MTOR and HIF1A, suggesting alternative regulatory pathways. Small molecules that disrupt protein-protein interactions, such as inhibitors of Atg12-Atg3, can modulate this activity.
Atg12 transferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATG5 | Diabetic kidney disease | Podocyte-specific knockout mice |
| ATG12 | Cancer (lung, etc.) | Xenograft models with ATG12 knockout or overexpression |
| HYPK | Neurodegeneration | HYPK knockout neuronal cells |
| ATG16L1 | Crohn's disease | ATG16L1 T300A knock-in mice |
| ATG7 | Metabolic disorders | Liver-specific ATG7 knockout mice |
Atg12 transferase activity in cancer
Autophagy plays a dual role in cancer, and Atg12 transferase activity is often dysregulated. In lung cancer cells, quercetin induces pro-apoptotic autophagy via SIRT1/AMPK signaling, which involves ATG12 conjugation. High levels of ATG12-ATG5 conjugate can promote survival in some cancers, making this activity a potential therapeutic target. Small-molecule inhibitors of Atg12-Atg3 interaction are being explored to sensitize cancer cells to chemotherapy.
Atg12 transferase activity in metabolic disorders
In diabetic kidney disease, ESRRA-ATG5-mediated mitophagy enhances arginine metabolism to alleviate disease, highlighting the importance of ATG12 conjugation in mitochondrial quality control. Dysregulation of autophagy contributes to podocyte injury and proteinuria, suggesting that modulating Atg12 transferase activity could be therapeutic.
Atg12 transferase activity in neurodegeneration
Impaired autophagy is a hallmark of neurodegenerative diseases. HYPK coordinates the degradation of polyneddylated proteins by autophagy, a process that depends on ATG12 conjugation. Defects in ATG12 transferase activity may lead to accumulation of toxic protein aggregates, contributing to neuronal death.
Atg12 transferase activity in infectious diseases
Autophagy is a key defense mechanism against intracellular pathogens. HIF1A and NFAT5 coordinate Na+-boosted antibacterial defense via enhanced autophagy and autolysosomal targeting, which requires ATG12 conjugation. Modulating this activity could enhance host defense against infections.
From Atg12 transferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ATG12 transferase activity require ATG10? | ATG10 knockout cell lines |
| What is the role of ATG12 in mitophagy? | ATG12 knockout mice or cells |
| How does ATG16L1 WD40 domain contribute to non-canonical autophagy? | ATG16L1 WD40 deletion knock-in mice |
| Can small molecules inhibit ATG12-ATG3 interaction? | In vitro conjugation assays with recombinant proteins |
| Does hypoxia-induced autophagy depend on ATG12 conjugation? | ATG5 knockout cells under hypoxia |
| What is the impact of ATG12 overexpression in cancer? | Tumor xenografts with ATG12 overexpression |
How to Study the Atg12 transferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | ATG12-ATG5 conjugate levels | Assessing autophagy induction |
| Immunofluorescence | LC3 puncta and ATG12-ATG5 localization | Visualizing autophagosomes |
| In vitro conjugation assay | Transfer of ATG12 to ATG5 | Screening inhibitors |
| CRISPR knockout screening | Genes required for autophagy | Identifying novel regulators |
| RNA-seq | Expression of autophagy genes | Transcriptional profiling |
| Proteomics | Protein interactions of ATG12 | Mapping the ATG12 interactome |
| Electron microscopy | Autophagosome ultrastructure | Confirming autophagy defects |
| Flow cytometry | GFP-LC3 flux | Quantifying autophagy in live cells |
Monitoring ATG12 conjugation by Western blot
Western blot analysis using anti-ATG12 or anti-ATG5 antibodies can detect the ATG12-ATG5 conjugate, which appears as a higher molecular weight band. This method is widely used to assess Atg12 transferase activity in cells and tissues.
Fluorescence microscopy for autophagosome formation
GFP-LC3 puncta formation is a standard assay for autophagosome formation, which depends on ATG12 conjugation. Co-localization of ATG12-ATG5 with LC3 can be visualized by immunofluorescence.
In vitro conjugation assays
Recombinant ATG7, ATG10, ATG12, and ATG5 can be used to reconstitute the conjugation reaction in vitro. This allows precise measurement of transferase activity and screening for inhibitors.
CRISPR screening for autophagy regulators
Genome-wide CRISPR knockout screens can identify genes that modulate Atg12 transferase activity. For example, cells lacking ATG12 or ATG5 are resistant to autophagy induction, and screens can uncover novel regulators.
How CRISPR Can Be Used to Study GO:0019777 Atg12 transferase activity
Knockout
CRISPR knockout of ATG12, ATG5, ATG7, or ATG10 abolishes Atg12 transferase activity, leading to autophagy deficiency. These models are used to study the role of autophagy in development, immunity, and disease [1,6].
Point Mutation
Point mutations in the catalytic residues of ATG7 or ATG10 can specifically inactivate the transferase activity without affecting protein stability. Such models help dissect the precise contribution of ATG12 conjugation to autophagy.
Knock-in
Knock-in of tagged ATG12 (e.g., HA-ATG12) allows for affinity purification and identification of ATG12 conjugates. This approach can reveal novel targets of Atg12 transferase activity.
Overexpression
Overexpression of ATG12 or ATG5 can enhance autophagy, which may protect against neurodegeneration or promote cancer cell survival. These models are useful for studying the consequences of increased Atg12 transferase activity.
How EDITGENE Supports Atg12 transferase activity Research
Researchers studying Atg12 transferase activity-related genes often need to determine whether a candidate gene is causally involved in autophagy regulation or disease pathogenesis. EDITGENE provides comprehensive CRISPR-based services to create precise cellular and animal models, enabling functional validation of genes in the ATG12 conjugation pathway.
Contact EDITGENE today to design your custom CRISPR model for Atg12 transferase activity research.
Frequently Asked Questions About Atg12 transferase activity
What is Atg12 transferase activity?
Atg12 transferase activity (GO:0019777) is a molecular function that catalyzes the covalent transfer of ATG12 from one protein to another, forming Y-ATG12 conjugates, as defined by the Gene Ontology.
What genes are involved in Atg12 transferase activity?
Key genes include ATG12, ATG5, ATG7, ATG10, and ATG16L1, which together mediate the conjugation of ATG12 to ATG5 [6,7].
What is the role of ATG12 in autophagy?
ATG12 is a ubiquitin-like protein that is conjugated to ATG5, forming a complex with ATG16L1 that is essential for LC3 lipidation and autophagosome formation.
How is Atg12 transferase activity regulated?
It is regulated by nutrient signaling via mTOR, transcription factors like TFEB, and post-translational modifications such as phosphorylation by AMPK [3,8].
What diseases are associated with Atg12 transferase activity?
Dysregulation is linked to cancer, diabetic kidney disease, neurodegeneration, and infectious diseases [1,3,4,5].
How can I study Atg12 transferase activity in the lab?
Common methods include Western blot for ATG12-ATG5 conjugate, in vitro conjugation assays, and CRISPR knockout models.
What are the synonyms for Atg12 transferase activity?
Synonyms include APG12 conjugating enzyme activity, APG12 ligase activity, Atg12 conjugating enzyme activity, and Atg12 ligase activity.
Is Atg12 transferase activity involved in non-canonical autophagy?
Yes, it is involved in non-canonical autophagy pathways, such as hypoxia-induced autophagy and antibacterial defense [2,5].
Can Atg12 transferase activity be targeted therapeutically?
Small-molecule inhibitors of Atg12-Atg3 interaction are being developed, and modulating this activity may have therapeutic potential in cancer and other diseases.
What CRISPR models are available for Atg12 transferase research?
EDITGENE offers knockout, point mutation, knock-in, and overexpression models for genes in the ATG12 conjugation pathway, as well as CRISPR library screening and bioinformatics services.
Conclusion
Atg12 transferase activity (GO:0019777) is a fundamental molecular function in autophagy, enabling the covalent conjugation of ATG12 to target proteins such as ATG5. This activity is essential for autophagosome formation and is implicated in a wide range of human diseases, including cancer, metabolic disorders, and neurodegeneration. Understanding its regulation and function provides opportunities for therapeutic intervention. EDITGENE offers comprehensive CRISPR services to facilitate research on Atg12 transferase activity and its associated genes, helping scientists uncover new insights into autophagy and disease.
References
- 1. Hu H et al.. 2026. ESRRA-ATG5-Mediated mitophagy enhances arginine metabolism to alleviate diabetic kidney disease.. Autophagy 22(4):666-690 PMID: 41376268
- 2. Choi H et al.. 2016. Hypoxia promotes noncanonical autophagy in nucleus pulposus cells independent of MTOR and HIF1A signaling.. Autophagy 12(9):1631-46 PMID: 27314664
- 3. Guo H et al.. 2021. Quercetin induces pro-apoptotic autophagy via SIRT1/AMPK signaling pathway in human lung cancer cell lines A549 and H1299 in vitro.. Thorac Cancer 12(9):1415-1422 PMID: 33709560
- 4. Ghosh DK et al.. 2022. HYPK coordinates degradation of polyneddylated proteins by autophagy.. Autophagy 18(8):1763-1784 PMID: 34836490
- 5. Neubert P et al.. 2019. HIF1A and NFAT5 coordinate Na(+)-boosted antibacterial defense via enhanced autophagy and autolysosomal targeting.. Autophagy 15(11):1899-1916 PMID: 30982460
- 6. Skach K et al.. 2024. Structure-activity relationship study of small-molecule inhibitor of Atg12-Atg3 protein-protein interaction.. Bioorg Med Chem Lett 112:129939 PMID: 39218407
- 7. Fletcher K et al.. 2018. The WD40 domain of ATG16L1 is required for its non-canonical role in lipidation of LC3 at single membranes.. EMBO J 37(4) PMID: 29317426
- 8. Shariq M et al.. 2024. PRKAA2, MTOR, and TFEB in the regulation of lysosomal damage response and autophagy.. J Mol Med (Berl) 102(3):287-311 PMID: 38183492
